journal article·2022-08Open access

Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology

Jong‐Chan Park, Natalia Barahona‐Torres, So‐Yeong Jang, Kin Y. Mok, Haeng Jun Kim, Sun‐Ho Han, Kwang‐Hyun Cho, Xiaopu Zhou, Amy K. Y. Fu, Nancy Y. Ip, Jieun Seo, Murim Choi, Hyobin Jeong, Daehee Hwang, Dong Young Lee, Min Soo Byun, Dahyun Yi, Jong Won Han, Inhee Mook‐Jung, John Hardy

Advanced Science· Volume 9· Issue 23

Abstract

Abstract Recent multi‐omics analyses paved the way for a comprehensive understanding of pathological processes. However, only few studies have explored Alzheimer’s disease (AD) despite the possibility of biological subtypes within these patients. For this study, unsupervised classification of four datasets (genetics, miRNA transcriptomics, proteomics, and blood‐based biomarkers) using Multi‐Omics Factor Analysis+ (MOFA+), along with systems‐biological approaches following various downstream analyses are performed. New subgroups within 170 patients with cerebral amyloid pathology (Aβ+) are revealed and the features of them are identified based on the top‐rated targets constructing multi‐omics factors of both whole (M‐TPAD) and immune‐focused models (M‐IPAD). The authors explored the characteristics of subtypes and possible key‐drivers for AD pathogenesis. Further in‐depth studies showed that these subtypes are associated with longitudinal brain changes and autophagy pathways are main contributors. The significance of autophagy or clustering tendency is validated in peripheral blood mononuclear cells (PBMCs; n = 120 including 30 Aβ‐ and 90 Aβ+), induced pluripotent stem cell‐derived human brain organoids/microglia (n = 12 including 5 Aβ‐, 5 Aβ+, and CRISPR‐Cas9 apolipoprotein isogenic lines), and human brain transcriptome (n = 78). Collectively, this study provides a strategy for precision medicine therapy and drug development for AD using integrative multi‐omics analysis and network modelling.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms · Dementia and Cognitive Impairment Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology University College London London WC1N 3BG UK

Department of Biochemistry and Biomedical Sciences College of Medicine Seoul National University Seoul 03080 Republic of Korea

Neuroscience Research Institute Medical Research Center College of Medicine Seoul National University Seoul 03080 Republic of Korea

SNU Korea Dementia Research Center College of Medicine Seoul National University Seoul 03080 Republic of Korea

Department of Bio and Brain Engineering Korea Advanced Institute of Science and Technology Daejeon 34141 Republic of Korea

Division of Life Science State Key Laboratory of Molecular Neuroscience Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay, Kowloon Hong Kong 999077 China

Hong Kong Center for Neurodegenerative Diseases Hong Kong Science Park Hong Kong 999077 China

Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen‐Hong Kong Institute of Brain Science Shenzhen Guangdong 518057 China

Department of Laboratory Medicine Severance Hospital Yonsei University College of Medicine Seoul 03722 Republic of Korea

European Molecular Biology Laboratory Genome Biology Unit Heidelberg 69117 Germany

Department of Biological Sciences Seoul National University Seoul 08826 Republic of Korea

Institute of Human Behavioral Medicine Medical Research Center Seoul National University Seoul 03080 Republic of Korea

Department of Psychiatry College of medicine Seoul National University Seoul 03080 Republic of Korea

Department of Neuropsychiatry Seoul National University Hospital Seoul 03080 Republic of Korea

Department of Psychiatry Pusan National University Yangsan Hospital Yangsan 50612 Republic of Korea

Biomedical Research Institute Seoul National University Hospital Seoul 03082 Republic of Korea

Funding

Korea Health Industry Development Institute · National Research Foundation of Korea

References (61)

Show source-provided references
1. 10.3389/fphar.2015.0022110.3389/fphar.2015.00221 ↗
2. Wang S. · J. Alzheimer's Dis. Parkinsonism Dementia · 2016 · 1 · 007
3. 10.1186/s13195-020-00722-210.1186/s13195-020-00722-2 ↗
4. 10.2174/15701590978760280510.2174/157015909787602805 ↗
5. 10.1016/j.brainresbull.2018.11.01210.1016/j.brainresbull.2018.11.012 ↗
6. 10.1177/089198871038357110.1177/0891988710383571 ↗
7. 10.1016/j.arr.2017.08.00510.1016/j.arr.2017.08.005 ↗
8. 10.1038/s41467-020-20440-510.1038/s41467-020-20440-5 ↗
9. 10.3389/fnins.2019.0091610.3389/fnins.2019.00916 ↗
10. 10.5483/BMBRep.2020.53.1.30910.5483/BMBRep.2020.53.1.309 ↗
11. 10.1038/ng.391610.1038/ng.3916 ↗
12. 10.1016/j.exger.2017.12.01910.1016/j.exger.2017.12.019 ↗
13. 10.1212/WNL.000000000000905810.1212/WNL.0000000000009058 ↗
14. 10.1126/sciadv.abb539810.1126/sciadv.abb5398 ↗
15. 10.1016/j.heliyon.2021.e0600010.1016/j.heliyon.2021.e06000 ↗
16. 10.1016/j.ebiom.2019.08.05110.1016/j.ebiom.2019.08.051 ↗
17. 10.1038/s41598-019-56826-910.1038/s41598-019-56826-9 ↗
18. 10.1200/CCI.20.0003510.1200/CCI.20.00035 ↗
19. 10.1371/journal.pone.020382410.1371/journal.pone.0203824 ↗
20. 10.15252/msb.2017812410.15252/msb.20178124 ↗
21. 10.1186/s13059-020-02015-110.1186/s13059-020-02015-1 ↗
22. 10.1007/s12026-014-8516-110.1007/s12026-014-8516-1 ↗
23. 10.1093/nar/gky113110.1093/nar/gky1131 ↗
24. 10.1038/s41597-019-0152-010.1038/s41597-019-0152-0 ↗
25. 10.1371/journal.pcbi.100457410.1371/journal.pcbi.1004574 ↗
26. 10.3390/nu1102038610.3390/nu11020386 ↗
27. 10.1023/A:100690242877610.1023/A:1006902428776 ↗
28. 10.1371/journal.pone.014079810.1371/journal.pone.0140798 ↗
29. 10.1186/1475-2840-13-7810.1186/1475-2840-13-78 ↗
30. 10.1016/j.cellsig.2014.08.01910.1016/j.cellsig.2014.08.019 ↗
31. 10.1002/jcb.2436210.1002/jcb.24362 ↗
32. 10.1186/s13578-016-0113-710.1186/s13578-016-0113-7 ↗
33. 10.1056/NEJMoa120275310.1056/NEJMoa1202753 ↗
34. 10.3389/fcell.2018.0012810.3389/fcell.2018.00128 ↗
35. 10.1016/j.cub.2018.12.02110.1016/j.cub.2018.12.021 ↗
36. 10.1016/j.diff.2021.08.00310.1016/j.diff.2021.08.003 ↗
37. 10.1038/nature0797610.1038/nature07976 ↗
38. 10.1016/j.molcel.2015.07.02110.1016/j.molcel.2015.07.021 ↗
39. 10.3390/ijms1804080210.3390/ijms18040802 ↗
40. 10.1159/00017596510.1159/000175965 ↗
41. 10.1002/jcp.1029410.1002/jcp.10294 ↗
42. 10.1126/scitranslmed.aaz229410.1126/scitranslmed.aaz2294 ↗
43. 10.1073/pnas.091171410710.1073/pnas.0911714107 ↗
44. 10.1248/bpb.33.95110.1248/bpb.33.951 ↗
45. 10.1080/15548627.2018.142702210.1080/15548627.2018.1427022 ↗
46. 10.3389/fnmol.2018.0029910.3389/fnmol.2018.00299 ↗
47. 10.3892/ol.2020.1158910.3892/ol.2020.11589 ↗
48. 10.1111/j.1749-6632.2012.06513.x10.1111/j.1749-6632.2012.06513.x ↗
49. 10.1210/er.2011-104910.1210/er.2011-1049 ↗
50. 10.1186/s13195-021-00814-710.1186/s13195-021-00814-7 ↗
51. 10.4306/pi.2017.14.6.85110.4306/pi.2017.14.6.851 ↗
52. 10.1093/brain/awy34710.1093/brain/awy347 ↗
53. 10.1016/S1474-4422(09)70299-610.1016/S1474-4422(09)70299-6 ↗
54. 10.1016/j.jalz.2011.03.00410.1016/j.jalz.2011.03.004 ↗
55. 10.1016/S1474-4422(14)70194-210.1016/S1474-4422(14)70194-2 ↗
56. Wirth M. · JAMA Neurol. · 2013 · 70 · 1512
57. 10.1016/j.neuroimage.2017.09.02010.1016/j.neuroimage.2017.09.020 ↗
58. 10.1002/ece3.577410.1002/ece3.5774 ↗
59. 10.1186/s12864-016-3198-910.1186/s12864-016-3198-9 ↗
60. 10.1186/s13024-018-0297-x10.1186/s13024-018-0297-x ↗
61. 10.1111/acel.1253010.1111/acel.12530 ↗